Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip H. Elsinga

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Nuclear Medicine Communications|February 4, 2015
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approachRogier Lange, Rob ter Heine, Clemens Decristoforo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 27, 2016
In vivo evaluation of [<sup>11</sup>C]preladenant positron emission tomography for quantification of adenosine A<sub>2A</sub> receptors in the rat brainXiaoyun Zhou, Shivashankar Khanapur, Johan R de Jong, et al.
Chemical Communications (Cambridge, England)|January 29, 2010
One pot 'click' reactions: tandem enantioselective biocatalytic epoxide ring opening and [3+2] azide alkyne cycloadditionLachlan S Campbell-Verduyn, Wiktor Szymański, Christiaan P Postema, et al.
Molecular Pharmaceutics|August 5, 2021
[<sup>18</sup>F]Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male RatsGonçalo S Clemente, Inês F Antunes, Jürgen W A Sijbesma, et al.
Current Pharmaceutical Design|April 6, 2012
Multimerization improves targeting of peptide radio-pharmaceuticalsGiuseppe Carlucci, Hildo J K Ananias, Zilin Yu, et al.
Nuclear Medicine and Biology|February 1, 2014
[(18)F]-(fluoromethoxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)propan-2-ol ([(18)F FPTC) a novel PET-ligand for cerebral beta-adrenoceptorsLeila Mirfeizi, Anna A Rybczynska, Aren van Waarde, et al.
Molecular Imaging and Biology|December 3, 2014
Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor OccupancyNisha K Ramakrishnan, Marianne Schepers, Gert Luurtsema, et al.
The AAPS Journal|September 8, 2016
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET StudyHeli Savolainen, Peter Meerlo, Philip H Elsinga, et al.
Oral Oncology|August 21, 2009
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancerLukas B Been, Harald J Hoekstra, Albert J H Suurmeijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancerHenderik L van Westreenen, David C P Cobben, Pieter L Jager, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Nuclear Medicine Communications|February 4, 2015
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approachRogier Lange, Rob ter Heine, Clemens Decristoforo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 27, 2016
In vivo evaluation of [<sup>11</sup>C]preladenant positron emission tomography for quantification of adenosine A<sub>2A</sub> receptors in the rat brainXiaoyun Zhou, Shivashankar Khanapur, Johan R de Jong, et al.
Chemical Communications (Cambridge, England)|January 29, 2010
One pot 'click' reactions: tandem enantioselective biocatalytic epoxide ring opening and [3+2] azide alkyne cycloadditionLachlan S Campbell-Verduyn, Wiktor Szymański, Christiaan P Postema, et al.
Molecular Pharmaceutics|August 5, 2021
[<sup>18</sup>F]Atorvastatin Pharmacokinetics and Biodistribution in Healthy Female and Male RatsGonçalo S Clemente, Inês F Antunes, Jürgen W A Sijbesma, et al.
Current Pharmaceutical Design|April 6, 2012
Multimerization improves targeting of peptide radio-pharmaceuticalsGiuseppe Carlucci, Hildo J K Ananias, Zilin Yu, et al.
Nuclear Medicine and Biology|February 1, 2014
[(18)F]-(fluoromethoxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)propan-2-ol ([(18)F FPTC) a novel PET-ligand for cerebral beta-adrenoceptorsLeila Mirfeizi, Anna A Rybczynska, Aren van Waarde, et al.
Molecular Imaging and Biology|December 3, 2014
Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor OccupancyNisha K Ramakrishnan, Marianne Schepers, Gert Luurtsema, et al.
The AAPS Journal|September 8, 2016
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET StudyHeli Savolainen, Peter Meerlo, Philip H Elsinga, et al.
Oral Oncology|August 21, 2009
[18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancerLukas B Been, Harald J Hoekstra, Albert J H Suurmeijer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 8, 2005
Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancerHenderik L van Westreenen, David C P Cobben, Pieter L Jager, et al.
Pageof 17